#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Netherton's syndrome Osteogenesis imperfecta IPEX syndrome Dedifferentiated liposarcoma Loss of consciousness Hyperinsulinaemic hypoglycaemia Hydrocephalus Neuroblastoma Non-Hodgkin's lymphoma unspecified histology aggressive recurrent Encephalopathy neonatal Candida infection Bone marrow disorder Severe myoclonic epilepsy of infancy CDKL5 deficiency disorder Acute on chronic liver failure More trials…

    Learn about Rare Diseases

    Breast angiosarcoma – Treatment Hairy cell leukaemia – Basic Information KBG syndrome – Treatment Idiopathic pulmonary fibrosis – Diagnostics Cytokine release syndrome – Treatment Wiskott-Aldrich syndrome – Treatment Alport’s syndrome Leiomyosarcoma recurrent Phenylketonuria – Treatment Lennox-Gastaut syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Marstacimab Arginine Testosterone Thiamine Nitrate Bp Imipramine Hydrochloride Ly3437943 Sodium Belzutifan Ursodoxicoltaurine Vutrisiran Buspirone Hydrochloride Rifapentine VRDN-003 Savolitinib Mirikizumab Apl-101 Cefazolin Olopatadine Disitamab Vedotin Golodirsen Gsk4011499 More therapies…

    Learn about Your Condition

    Uveitis Infant sedation Psychological trauma Breast cancer stage III Pseudomyxoma peritonei Obesity Aortic disorder Urethral stenosis Acute HIV infection Metachromatic leukodystrophy Meniere's disease Liver transplant rejection Sciatica Metastatic malignant melanoma Chorioretinitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Pain Relief After Wisdom Tooth Surgery Using Etoricoxib and Celecoxib for Patients Undergoing Mandibular M3 Removal

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Etoricoxib
    • Celecoxib
    Hungary

  • Study on Choline Alfoscerate for Patients with Mild Cognitive Impairment

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • CHOLINE ALFOSCERATE
    Italy

  • Study on Methadone, Fentanyl, and Oxycodone for Reducing Pain After Heart Surgery in Adults

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Procedural pain
    Investigated Drugs:
    • Methadone Hydrochloride
    • Oxycodone Hydrochloride
    • Fentanyl Citrate
    Denmark

  • Study Comparing Secretin Synthetic Human and Endoscopic Aspiration Techniques for Analyzing Pancreatic Cancer in Patients with Intraductal Papillary Mucinous Neoplasia

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Intraductal papillary mucinous neoplasm
    Investigated Drugs:
    • SECRETIN SYNTHETIC HUMAN
    Spain

  • Evaluation of tamsulosin and furosemide combination therapy after shock wave lithotripsy in patients with kidney stones

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Nephrolithiasis
    Investigated Drugs:
    • Furosemide
    • Tamsulosin Hydrochloride
    • Ibuprofen
    Denmark

  • Study on the Safety and Effects of YTB323 and Drug Combination for Patients with Treatment-Resistant Generalized Myasthenia Gravis

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    • Rapcabtagene Autoleucel
    • Cyclophosphamide
    • Fludarabine Phosphate
    France
Previous Page
1 … 836 837 838 839 840 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!